Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
Total Valuation
Bio-Techne has a market cap or net worth of $8.31B. The enterprise value is $8.25B.
Market Cap$8.31B
Enterprise Value$8.25B
Share Statistics
Bio-Techne has 155,549,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding155,549,590
Owned by Insiders0.25%
Owned by Institutions28.85%
Financial Efficiency
Bio-Techne’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.16%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.16%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee393.43K
Profits Per Employee23.68K
Employee Count3,100
Asset Turnover0.48
Inventory Turnover2.27
Valuation Ratios
The current PE Ratio of Bio-Techne is 116.3. Bio-Techne’s PEG ratio is ―.
PE Ratio116.3
PS Ratio―
PB Ratio―
Price to Fair Value4.22
Price to FCF―
Price to Operating Cash Flow28.78
PEG Ratio―
Income Statement
In the last 12 months, Bio-Techne had revenue of 1.22B and earned 73.40M in profits. Earnings per share was 0.47.
Revenue1.22B
Gross Profit790.27M
Operating Income102.25M
Pretax Income98.46M
Net Income73.40M
EBITDA216.88M
Earnings Per Share (EPS)0.47
Cash Flow
In the last 12 months, operating cash flow was 287.56M and capital expenditures -31.01M, giving a free cash flow of 256.55M billion.
Operating Cash Flow287.56M
Free Cash Flow256.55M
Free Cash Flow per Share1.65
Dividends & Yields
Bio-Techne pays an annual dividend of $0.08, resulting in a dividend yield of 0.6%
Dividend Per Share$0.08
Dividend Yield0.6%
Payout Ratio16.58%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change-26.48%
50-Day Moving Average53.73
200-Day Moving Average59.87
Relative Strength Index (RSI)45.12
Average Volume (3m)2.31M
Important Dates
Bio-Techne upcoming earnings date is Nov 4, 2025, Before Open (Confirmed).
Last Earnings DateAug 6, 2025
Next Earnings DateNov 4, 2025
Ex-Dividend DateAug 18, 2025
Financial Position
Bio-Techne as a current ratio of 3.46, with Debt / Equity ratio of 23.14%
Current Ratio3.46
Quick Ratio2.38
Debt to Market Cap0.04
Net Debt to EBITDA1.30
Interest Coverage Ratio12.02
Taxes
In the past 12 months, Bio-Techne has paid 25.06M in taxes.
Income Tax25.06M
Effective Tax Rate0.25
Enterprise Valuation
Bio-Techne EV to EBITDA ratio is 38.67, with an EV/FCF ratio of 32.69.
EV to Sales6.88
EV to EBITDA38.67
EV to Free Cash Flow32.69
EV to Operating Cash Flow29.16
Balance Sheet
Bio-Techne has $162.19M in cash and marketable securities with $444.06M in debt, giving a net cash position of $281.87M billion.
Cash & Marketable Securities$162.19M
Total Debt$444.06M
Net Cash$281.87M
Net Cash Per Share$1.81
Tangible Book Value Per Share$3.63
Margins
Gross margin is 64.80%, with operating margin of 8.38%, and net profit margin of 6.02%.
Gross Margin64.80%
Operating Margin8.38%
Pretax Margin8.07%
Net Profit Margin6.02%
EBITDA Margin17.78%
EBIT Margin8.77%
Analyst Forecast
The average price target for Bio-Techne is $66.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$66.00
Price Target Upside24.72% Upside
Analyst ConsensusStrong Buy
Analyst Count13
Revenue Growth Forecast5.23%
EPS Growth Forecast-56.70%